Unitedhealth Group Inc. ( (UNH) ) has released its Q4 earnings. Here is a breakdown of the information Unitedhealth Group Inc. presented to its investors.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
UnitedHealth Group Inc., a major player in the healthcare and well-being sector, operates through its two complementary businesses, Optum and UnitedHealthcare, which provide health benefits and care services globally.
In its 2024 earnings report, UnitedHealth Group reported revenues of $400.3 billion, marking an 8% increase from the previous year. The company experienced growth in both its UnitedHealthcare and Optum segments, with an increase in the number of domestic consumers served and a significant expansion in value-based care patients.
Key financial highlights include earnings from operations totaling $32.3 billion, with adjusted earnings excluding certain costs reaching $34.4 billion. The company’s medical care ratio rose to 85.5%, influenced by Medicare funding reductions and other factors, while the operating cost ratio improved to 13.2% due to strategic business refinements. Cash flows from operations were $24.2 billion, allowing for substantial returns to shareholders through dividends and share repurchases.
The Optum segment saw a 12% rise in revenues, with notable performance in Optum Rx and Optum Health. Despite facing challenges like a cyberattack, which impacted Optum Insight revenues, the company managed to advance its pharmacy services and expand its client base.
Looking ahead, UnitedHealth Group has affirmed its 2025 performance outlook, expecting revenues between $450 billion to $455 billion, signaling continued growth and strategic strengthening across its business segments.
